Buscar
Mostrando ítems 51-60 de 152
Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine response
(WILEY-BLACKWELL PUBLISHING, INC, 2010)
P>Background
Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
(Biomed Central LtdLondonInglaterra, 2010)
Pre-treatment prediction of response to peginterferon plus ribavirin in chronic hepatitis C genotype 3
(Baishideng Publishing Group Inc, 2015-04)
AIM: To evaluate pre-treatment factors associated with sustained virological response (SVR) in patients with hepatitis C virus (HCV) genotype 3 treated with peginterferon and ribavirin (RBV). METHODS: We retrospectively ...
Polimorfismo del IL28B asociado a respuesta al tratamiento con peginterferón y ribavirina en pacientes con hepatitis C crónica
(Universidad de San Martín de Porres, 2014)
OBJETIVO: Estudiar en una población peruana de pacientes con infección por virus de hepatitis C (VHC) los efectos del polimorfismo IL28B rs12979860 CC, CT y TT en la respuesta al tratamiento con interferón pegilado y ...
A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
(W B SAUNDERS CO-ELSEVIER INC, 2010)
BACKGROUND & AIMS: A sustained virologic response (SVR) to therapy for hepatitis C virus (HCV) infection is defined as the inability to detect HCV RNA 24 weeks after completion of treatment. Although small studies have ...
Cost effectiveness of peginterferon alfa-2B combined with ribavirin for the treatment of chronic hepatitis C in Brazil
(Brazilian Society of Infectious Diseases, 2009-06-01)
The treatment of chronic hepatitis C (CHC) with peginterferon alpha-2b/ribavirin (PegIFN + Rib) produced larger sustained viral response (SVR) compared to the conventional (non-pegylated) interferon/ribavirin (IFN + Rib), ...
Induction pegylated interferon Alfa-2a and high dose ribavirin do not increase SVR in heavy patients with HCV genotype 1 and high viral loads
(2010-12-01)
Background & Aims Patients infected with hepatitis C virus (HCV) genotype 1, body weight <85 kg, and high baseline viral load respond poorly to standard doses of pegylated interferon (peginterferon) and ribavirin. We ...
A global view of hepatitis C: Physician knowledge, opinions, and perceived barriers to care
(Wiley-blackwellHobokenEUA, 2013)
Insulin resistance, hepatic steatosis and hepatitis C: A complex relationship with relevant clinical implications
(ELSEVIER ESPANA, 2010)
Insulin resistance (IR) is a common pathophysiological condition where higher-than-normal concentrations of insulin are needed to maintain a normal glycemia and adequate glucose utilization in insulin target tissues. A ...
Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
(W B SAUNDERS CO-ELSEVIER INC, 2009)
Background & Aims: Treatment with peginterferon alfa and ribavirin produces a sustained virologic response (SVR) in approximately 60% of hepatitis C virus (HCV)-infected patients. Alternate options are needed for patients ...